Navigation Links
Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results
Date:5/21/2013

RONKONKOMA, N.Y., May 21, 2013 /PRNewswire/ -- Lakeland Industries, Inc. (NASDAQ: LAKE), a leading global manufacturer of industrial protective clothing for industry, municipalities, healthcare and first responders on the federal, state and local levels, today announced that the Company accepted a commitment letter from a bank for a Senior Credit Facility subject to certain terms and conditions and is currently working towards closing this financing.  However, no assurances can be given that this transaction or any transaction will be consummated.

(Logo: http://photos.prnewswire.com/prnh/20120611/NY21959LOGO )

The Company has received a letter from The Nasdaq Stock Market notifying the Company that it is not in compliance with the Nasdaq Listing Rule 5250(c)(1) because it had not filed its Annual Report on Form 10-K for the fiscal year ended January 31, 2013 on a timely basis with the Securities and Exchange Commission. Under Nasdaq rules, the Company has 60 calendar days, or until July 16, 2013, to regain compliance with Nasdaq's filing requirements for continued listing. The Company has filed its 2013 Form 10-K and believes it is now in full compliance.

Declining sales in FY13 led to quarterly losses in Brazil, which led to the necessity of writing off all goodwill, certain intangibles, and deferred tax assets of Brazil. These factors led to a default on the TD Bank loan, which in turn created substantial doubt about our ability to continue as a going concern. Successful completion of the proposed new financing, in management's opinion, would relieve this condition. Thus, we engaged with new lenders and considered other options, such as the sale of the Company, the sale of assets which has occurred, and a refinance of the TD Bank loan. We will continue pursuing all options to maximi
'/>"/>

SOURCE Lakeland Industries, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. Lakeland Industries, Inc. Announces Completion of Line of Credit with HSBC UK
2. Lakeland Industries, Inc. Issues Updates on Fiscal 2013
3. Lakeland Industries to Report Fiscal Fourth Quarter and Year End Financial Results and Conduct Conference Call
4. Amendia, Inc. and Medline Industries, Inc. Announce Investment and Strategic Business Alliance
5. Lower Operating Expense Augments Digital X-rays Uptake Across Industries, Finds Frost & Sullivan
6. Sun Pharmaceutical Industries, Inc. Issues Nationwide Voluntary Recall of One Lot of Nimodipine Capsules due to Crystallization of the Fill Material
7. Fero Industries, Inc. Issues Corporate Update
8. Fero Industries, Inc. Changes Name to PharmaRoth Labs, Inc.
9. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
10. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
11. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... and HOUSTON, TX , ... the "Company") (TSX-V: EPI) and Bloom Burton & Co. ... from voluntary contractual lock-up (the "Lock-Up") 2,353,130 common shares ... Common Shares originally subject to the Lock-Up. Of the ... be free trading immediately upon release from the Lock-Up ...
(Date:2/27/2015)... -- Boston Scientific Corporation (NYSE: BSX ) is ... Conference on March 10 in Miami Beach ... vice president and chief financial officer, and Susie ... a 25-minute question and answer session regarding the company ... Following a 5-minute break, a question and answer session ...
(Date:2/27/2015)... Feb. 27, 2015   Synageva BioPharma Corp. ... company developing therapeutic products for rare diseases, joins ... European Organisation for Rare Diseases™ (EURORDIS™), The Global ... observing Rare Disease Day. On the ... industry, and other participants conduct special events to ...
Breaking Medicine Technology:ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 2ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 3ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 4Boston Scientific to Participate in the Barclays 2015 Annual Healthcare Conference 2Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 2Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 3Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 4Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 5Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 6
... Nov. 2, 2010 /PRNewswire-Asia-FirstCall/ -- BMP Sunstone Corporation (Nasdaq: ... today announced that the Company plans to release third ... after the market closes. The Company will ... November 9, 2010 to discuss its results.  Listeners may ...
... 2, 2010 Arlington Medical Resources (AMR), ... and diagnostic imaging industries, finds that the leading driver ... States is activity against key drug-resistant pathogens. Such pathogens ... and multidrug-resistant Steptococcus pneumonia. "Nosocomial ...
Cached Medicine Technology:BMP Sunstone to Report Third Quarter 2010 Financial Results 2Activity Against Key Drug-Resistant Pathogens is the Most Important Attribute Influencing Surveyed Physicians' Antibiotic Selection for Nosocomial Pneumonia in the U.S. 2
(Date:2/27/2015)... Laguna Hills, CA (PRWEB) February 27, 2015 ... has been chosen as their Sage ERP Document Management ... ERP, Sage 300 ERP, Sage CRM and other complimentary ... ADSS Global have worked side-by-side for many years to ... their Sage ERP applications. , “We are thrilled ...
(Date:2/27/2015)... In New York City, a Brooklyn dentist is ... care from his Sheepshead Bay­neighborhood practice. Dr. Leonard ... Heart, and will be hosting a charity event on ... are in need of fillings, extractions, or professional dental ... high­quality service of Dr. Umanoff's practice on the Dentistry ...
(Date:2/27/2015)... February 27, 2015 The federal court ... that allege use of the statin medication can increase ... issued a new order pertaining discovery in the cases ... Liebhard LLP comments. The Order, which was issued in ... February 25th, directs the parties to schedule certain witness ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 According to ... General Hospital on June 25, 2013 and underwent a ... stomach through her mouth. Because the duodenoscope allegedly ... with the antibiotic-resistant “superbug” carbapenem-resistant Enterobacteriaceae (CRE). ... Court of Cook County on behalf of Ms. Pirolli ...
(Date:2/27/2015)... 2015 Adding to its rich ... Benedict Advertising & Marketing has added Sedation Systems ... company’s patented NITROUSEAL® N20 closed mask and breathing ... sedation. , Sedation Systems, http://www.sedationsystems.com is ... new level, though it focuses primarily on pediatric ...
Breaking Medicine News(10 mins):Health News:Altec Announces 2014 Sage ERP Document Management Partner of the Year Award Recipient 2Health News:Dr. Umanoff Unites with Dentistry from the Heart to Provide Community with Charitable Dental Care 2Health News:Dr. Umanoff Unites with Dentistry from the Heart to Provide Community with Charitable Dental Care 3Health News:Federal Lipitor Litigation Issues New Order Pertaining to Discovery in Bellwether Cases, Bernstein Liebhard LLP Comments 2Health News:Federal Lipitor Litigation Issues New Order Pertaining to Discovery in Bellwether Cases, Bernstein Liebhard LLP Comments 3Health News:Lawsuit Alleges Blame on Scope Manufacturer for "Superbug" Outbreak 2Health News:Benedict Advertising & Marketing Signs Sedation Systems 2
... (CCC) have selected Turning The Tide Together as the theme ... be held in Washington, D.C. from 22 27 July ... moment in time, emphasizing that the AIDS epidemic has reached ... in HIV treatment and biomedical prevention, the momentum for a ...
... TUESDAY, Sept. 20 (HealthDay News) -- People affected by ... without it to develop schizophrenia, and those with schizophrenia ... than people who are not schizophrenic, a new study ... between the two conditions may be due to genetic, ...
... Mitchell, IGB faculty member in the Mining Microbial Genomes ... the Department of Chemistry, is a recipient of the ... The award recognizes bold ideas from some of the ... award, given over a period of five years, supports ...
... about cancer and cancer treatments can feel like learning a ... to understand their treatment options, and the risks and benefits ... death decisions that may affect their survival and they need ... tests can be serious. Patients need to know what kind ...
... An analysis of more than 30,000 cancer patients has ... doctors may realize, causing additional hospitalizations and driving up the ... Duke Cancer Institute researcher. The study, which will be ... in Stockholm, found that as many as one in five ...
... method of family planning developed by researchers from the ... effectively meets the needs of users that they continue to ... that women who follow the Standard Days Method, are likely ... Results of the large, multi-country study of 1659 women appear ...
Cached Medicine News:Health News:Turning the Tide Together: AIDS 2012 theme selected 2Health News:Researchers Find Link Between Epilepsy, Schizophrenia Risk 2Health News:10 ways to make better decisions about cancer care 2Health News:10 ways to make better decisions about cancer care 3Health News:Costly blood clots more common than expected among cancer patients 2Health News:Long-term effectiveness of new family planning method shown in study 2
1.7/2.2 mm Delta System resorbable implant technology merges science and simplicity for a superior craniomaxillofacial surgery product. The system consists of resorbable bone plates and screws fabric...
... A-scan Sonomed-315 is intended for visualization of ... of midline shifts in the brain, evaluation ... easy to use, the Sonomed-315 offers quick ... mode allows to identify the anatomic structures ...
... a scaleable device that works ... platelet plasma or buffy coat. ... coat must be prepared independently ... Starting volume and concentration factor ...
The Ultrafoam Collagen Sponge is indicated in all surgical procedures as an adjunct to hemostasis when control by ligature or conventional procedures are ineffective or impractical....
Medicine Products: